Aspiriant LLC’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Hold
4,083
0.01% 283
2026
Q1
$329K Hold
4,083
0.01% 266
2025
Q4
$314K Hold
4,083
0.01% 269
2025
Q3
$307K Hold
4,083
0.01% 248
2025
Q2
$280K Hold
4,083
0.01% 267
2025
Q1
$246K Buy
+4,083
New +$246K 0.01% 265

Other funds holding AVEM

Aspiriant LLC's AVEM Position: Q2 2026 in Review

Aspiriant LLC held its Avantis Emerging Markets Equity ETF (AVEM) position steady in Q2 2026 at 4,083 shares worth $394K. The position accounts for 0.01% of the portfolio, ranked #283.

Aspiriant LLC first reported a position in AVEM in Q1 2025 and has held it in 6 quarters since. 1,006 funds tracked by Wall St. Rank hold AVEM as of Q2 2026.

  • Aspiriant LLC held 4,083 shares of Avantis Emerging Markets Equity ETF worth $394K as of Q2 2026.
  • Aspiriant LLC left its Avantis Emerging Markets Equity ETF share count unchanged in Q2 2026.
  • Avantis Emerging Markets Equity ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #283 holding.
  • Aspiriant LLC first reported a position in Avantis Emerging Markets Equity ETF in Q1 2025 and has held it in 6 quarters since.
  • 1,006 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.